These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36634704)

  • 1. A case of polycystic ovary syndrome with inevitable miscarriage and multi-site venous thrombosis caused by hereditary protein C deficiency.
    Zhong M; Tu Y; Peng X; Song Y; Zhou J; Zhang X; Xu Q; Li L
    Gynecol Endocrinol; 2022 Dec; 38(12):1153-1157. PubMed ID: 36634704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
    Nazli Y; Colak N; Aksoy ON; Cakir O
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):331-3. PubMed ID: 21415709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study.
    Pan ML; Chen LR; Chen KH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444016
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.
    Tang L; Guo T; Yang R; Mei H; Wang H; Lu X; Yu J; Wang Q; Hu Y
    PLoS One; 2012; 7(4):e35773. PubMed ID: 22545135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.
    Okoroh EM; Boulet SL; George MG; Craig Hooper W
    Thromb Res; 2015 Dec; 136(6):1165-8. PubMed ID: 26489726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone-dependent gynaecological disorders and contraceptive modalities in women with a history of venous thromboembolic event: The THROMBOGYN study.
    Mottais-Cosnefroy V; Pecourt M; Yannoutsos A; Fels A; Beaussier H; Alran S; Priollet P; Hugon-Rodin J
    J Med Vasc; 2022; 47(5-6):228-237. PubMed ID: 36464417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
    Gariani K; Hugon-Rodin J; Philippe J; Righini M; Blondon M
    Thromb Res; 2020 Jan; 185():102-108. PubMed ID: 31790999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are women with polycystic ovary syndrome resistant to activated protein C?
    Atiomo WU; Condon J; Adekanmi O; Friend J; Wilkin TJ; Prentice AG
    Fertil Steril; 2000 Dec; 74(6):1229-32. PubMed ID: 11119756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.
    Okoroh EM; Hooper WC; Atrash HK; Yusuf HR; Boulet SL
    Am J Obstet Gynecol; 2012 Nov; 207(5):377.e1-8. PubMed ID: 22959762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis.
    Bird ST; Hartzema AG; Brophy JM; Etminan M; Delaney JA
    CMAJ; 2013 Feb; 185(2):E115-20. PubMed ID: 23209115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy-associated thrombosis.
    Pabinger I; Grafenhofer H
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):482-4. PubMed ID: 13677267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher chromosomal aberration rate in miscarried conceptus from polycystic ovary syndrome women undergoing assisted reproductive treatment.
    Li Y; Wang L; Xu J; Niu W; Shi H; Hu L; Zhang Y; Zhang M; Bao X; Zhang N; Sun Y
    Fertil Steril; 2019 May; 111(5):936-943.e2. PubMed ID: 30922640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study.
    Luo L; Gu F; Jie H; Ding C; Zhao Q; Wang Q; Zhou C
    Reprod Biomed Online; 2017 Nov; 35(5):576-582. PubMed ID: 28802704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol for subfertile women with polycystic ovary syndrome.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome.
    de Medeiros SF
    Reprod Biol Endocrinol; 2017 Dec; 15(1):93. PubMed ID: 29216881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-related thrombosis risk in patients with protein C deficiency and comparison with pregnant women with heterozygous factor V Leiden mutation.
    Rugeri L; Desage S; Khouatra L; Battie C; Doret-Dion M; Trzeciak C; Dargaud Y
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):55-59. PubMed ID: 31833868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.